Navigation Links
BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
Date:9/26/2007

WOBURN, Mass., Sept. 26 /PRNewswire/ -- BioProcessors Corporation, a leading innovator of high-throughput cell culture-based solutions for biopharmaceutical process development, expands its Woburn operations and launches new SimCell Services offering.

"We continue to see strong interest in our SimCell technology," said Jonathan Rennert, President and CEO, BioProcessors Corporation. "The biopharmaceutical industry is accelerating its pace to clinical trials in order to identify successful therapeutic candidates sooner. Expanding our capacity and scope allows the company to respond more quickly and effectively to this key market need."

A second SimCell System was recently installed as part of an expanded laboratory and training wing at BioProcessors' Woburn facility. "Two high- throughput Robotic Systems, along with supporting analytical instrumentation and a new multi-media customer training center, provide our new team of cell culture specialists with much more comprehensive applications development and training capabilities," added Rennert. "We are now positioned to expand customer access to SimCell technology through the introduction of our new SimCell Services."

SimCell Services are customized service offerings tailored to meet specific cell culture application requirements of BioProcessors' clients. They provide access to SimCell technology through a hosted cell culture development project, which can range in scope from a simple screening experiment to more comprehensive production clone selection, clone stability, media optimization, or process development experiments. SimCell Services help clients gain better insight into their bioprocesses and reduce development risk by enabling the design of robust, optimized bioprocesses, faster and more efficiently.

About BioProcessors Corporation

BioProcessors Corporation is a developer and provider of micro-engineered solutions for cell culture-based upstream bioprocess development. The Company's SimCell technology provides the capability to perform high throughput cell culture experiments for the development and optimization of biopharmaceutical manufacturing processes. The high throughput capability of the system enables execution of full and fractional factorial statistical experiments at a fraction of the time and cost associated with conventional scale-down technologies. The result is greater insight and reduced risk for bioprocess development decision making.

For more information on BioProcessors Corporation, contact Eric Denoyer, Marketing Director, BioProcessors Corporation +1 781-305-8867, e.denoyer@bioprocessors.com, or visit http://www.bioprocessors.com.


'/>"/>
SOURCE BioProcessors Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology: